Erratum: A cell cycle regulatory network controlling NF-κB subunit activity and function (EMBO Journal (2007) 26:(4841-4855) DOI: 10.1038/sj.emboj.7601899);A cell cycle regulatory network controlling NF-κB subunit activity and function

EMBO Journal

Volumn 26, Issue 23, 2007, Pages 4841-4855

  Barré, Benjamin ^a   Perkins, Neil D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cell cycle; IKK; NF B; Transcription

Indexed keywords

CHECKPOINT KINASE 1; CYCLIN D1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; PROTEIN KINASE B; S PHASE KINASE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; EMBRYO; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 36549036709     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601899     Document Type: Erratum

References (46)

1. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, Thimmapaya B, Pestell RG (1999) Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem 274: 34186-34195
2. Bain J, Plater L, Elliott M, Shpiro N, Hastie J, McLauchlan H, Klevernic I, Arthur S, Alessi D, Cohen P (2007) The selectivity of protein kinase inhibitors; a further update. Biochem J Sep 13 (E-pub ahead of print)
3. Bromberg JF, Fan Z, Brown C, Mendelsohn J, Darnell Jr JE (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ 9: 505-512
4. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-κB. Mol Cell 13: 853-865
5. Campbell KJ, Witty JM, Rocha S, Perkins ND (2006) Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-κB transactivation. Cancer Res 66: 929-935
6. Ciana P, Neri A, Cappellini C, Cavallo F, Pomati M, Chang CC, Maiolo AT, Lombardi L (1997) Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene 14: 1805-1810
7. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin Jr AS (2000) Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19: 1123-1131
8. Demicco EG, Kavanagh KT, Romieu-Mourez R, Wang X, Shin SR, Landesman-Bollag E, Seldin DC, Sonenshein GE (2005) RelB/p52 NF-κB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IκB-α expression and promote carcinogenesis of the mammary gland. Mol Cell Biol 25: 10136-10147
9. Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE (2005) Inducible IκB kinase/IκB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-κB activation in breast cancer cells. Cancer Res 65: 11375-11383
10. Grdina DJ, Meistrich ML, Meyn RE, Johnson TS, White RA (1984) Cell synchrony techniques. I. A comparison of methods. Cell Tissue Kinet 17: 223-236
11. Grumont R, Lock P, Mollinari M, Shannon FM, Moore A, Gerondakis S (2004) The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-κB-dependent c-myc expression. Immunity 21: 19-30
12. Gustin JA, Korgaonkar CK, Pincheira R, Li Q, Donner DB (2006) Akt regulates basal and induced processing of NF-κB2 (p100) to p52. J Biol Chem 281: 16473-16481
13. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin Jr AS (1999) NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799
14. Hann SR, Thompson CB, Eisenman RN (1985) c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314: 366-369
15. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M (1999) NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19: 2690-2698
16. Hoberg JE, Yeung F, Mayo MW (2004) SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol Cell 16: 245-255
17. Ishikawa H, Carrasco D, Claudio E, Ryseck RP, Bravo R (1997) Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2. J Exp Med 186: 999-1014
18. Joyce D, Albanese C, Steer J, Fu M, Bouzahzah B, Pestell RG (2001) NF-κB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev 12: 73-90
19. Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM (2000) NF-κB activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. J Biol Chem 275: 32338-32346
20. Kim HJ, Hawke N, Baldwin AS (2006) NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ 13: 738-747
21. La Rosa FA, Pierce JW, Sonenshein GE (1994) Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol Cell Biol 14: 1039-1044
22. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, Cheresh DA, Karin M (2007) Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694
23. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125: 665-677
24. Ouyang W, Ma Q, Li J, Zhang D, Liu ZG, Rustgi AK, Huang C (2005) Cyclin D1 induction through IκB kinase β/nuclear factor-κB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res 65: 9287-9293
25. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB (2005) Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18: 71-82
26. Perkins ND (2006) Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 25: 6717-6730
27. Perkins ND (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8: 49-62
28. Petermann E, Caldecott KW (2006) Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5: 2203-2209
29. Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, Piwnica-Worms H, Hibshoosh H, Parsons R (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7: 193-204
30. Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH (1985) Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4: 2009-2015
31. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938-6947
32. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND (2005) Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 24: 1157-1169
33. Rocha S, Martin AM, Meek DW, Perkins ND (2003) p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol Cell Biol 23: 4713-4727
34. Sabbah M, Courilleau D, Mester J, Redeuilh G (1999) Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96: 11217-11222
35. Saccani S, Pantano S, Natoli G (2003) Modulation of NF-κB activity by exchange of dimers. Mol Cell 11: 1563-1574
36. Schneider G, Saur D, Siveke JT, Fritsch R, Greten FR, Schmid RM (2006) IKKα controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J 25: 3801-3812
37. Schumm K, Rocha S, Caamano J, Perkins ND (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. EMBO J 25: 4820-4832
38. Tashiro E, Tsuchiya A, Imoto M (2007) Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98: 629-635
39. Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F, Gelinas C, Rabson AB (1994) Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9: 2335-2344
40. Thompson CB, Challoner PB, Neiman PE, Groudine M (1985) Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314: 363-366
41. Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M, Frati L, Gulino A, Screpanti I (2006) Notch3 and pre-TCR interaction unveils distinct NF-κB pathways in T-cell development and leukemia. EMBO J 25: 1000-1008
42. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG (1998) Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol 18: 3212-3222
43. Westerheide SD, Mayo MW, Anest V, Hanson JL, Baldwin Jr AS (2001) The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition. Mol Cell Biol 21: 8428-8436
44. White RA, Grdina DJ, Meistrich ML, Meyn RE, Johnson TS (1984) Cell synchrony techniques. II. Analysis of cell progression data. Cell Tissue Kinet 17: 237-245
45. Xiao G, Harhaj EW, Sun SC (2001) NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol Cell 7: 401-409
46. Zhang J, Warren MA, Shoemaker SF, Ip MM (2007) NFκB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFκB2/p52 and RelB. Endocrinology 148: 268-278